Literature DB >> 13810741

Treatment of "refractory" ascites with a new aldosterone antagonist in patients with cirrhosis.

B F CLOWDUS, J A HIGGINS, J W ROSEVEAR, W H SUMMERSKILL.   

Abstract

Entities:  

Keywords:  LIVER CIRRHOSIS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13810741

Source DB:  PubMed          Journal:  Proc Staff Meet Mayo Clin        ISSN： 0092-699X


× No keyword cloud information.
  7 in total

1.  Long-term medical management and complications of 'resistant' ascites.

Authors:  W H SUMMERSKILL; B F CLOWDUS; J W ROSEVEAR
Journal:  Gut       Date:  1961-12       Impact factor: 23.059

2.  The aetiology and management of ascites in patients with hepatic cirrhosis: a review.

Authors:  S SHERLOCK; S SHALDON
Journal:  Gut       Date:  1963-06       Impact factor: 23.059

3.  Biochemical studies of the ascitic fluid in hepatic cirrhosis.

Authors:  S BERENDSOHN
Journal:  Am J Dig Dis       Date:  1962-02

4.  Diuretics: a critical evaluation.

Authors:  E M HELLER
Journal:  Can Med Assoc J       Date:  1962-06-02       Impact factor: 8.262

5.  [On hyponatremia syndromes and their analysis by electrolyte determination in erythrocytes].

Authors:  H JAHRMAERKER; R RIECKER
Journal:  Klin Wochenschr       Date:  1961-04-01

6.  [Studies with SU 4885 (metopirone) in patients with refractory ascites and edemas].

Authors:  F H FRANKEN; K IRMSCHER; H von SCHWEINITZ
Journal:  Klin Wochenschr       Date:  1962-02-01

7.  A comparison of the use of Aldactone and Aldactone A in the treatment of hepatic ascites.

Authors:  S SHALDON; J A RYDER; M GARSENSTEIN
Journal:  Gut       Date:  1963-03       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.